NLB Publications

Written by the IMF Nurse Leadership Board, these tools and manuscripts have been published in prestigious medical journals.

Patient and Healthcare Provider Education Tip Sheets
October 04, 2017
Patients with multiple myeloma (MM) often deal with short- and long-term side effects of the treatment and disease sequelae. Reasons for inadequately managed symptoms are multifactorial. Patient and healthcare provider educational tip sheets that appear throughout this supplement are grouped together in this document.
Myelosuppression, Bone Disease, and Acute Renal Failure: Evidence-Based Recommendations for Oncologic Emergencies
October 04, 2017
Oncologic emergencies associated with multiple myeloma include myelosuppression (anemia, neutropenia, and thrombocytopenia), bone-related emergencies, and acute renal failure. This article reviews the pathophysiology of these multiple myeloma-associated oncology emergencies and provides a framework for assessment and effective intervention.
Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma
October 04, 2017
About 85% of patients with multiple myeloma develop bone disease. In these patients, lytic bone lesions can cause fractures, poor circulation, blood clots, pain, poor mobility, and decreased quality of life. This article presents consensus statements to guide nurses in the assessment and management of bone disease, pain, and mobility in patients with multiple myeloma at varying points in their disease trajectory.
Heart and Lung Complications: Assessment and Prevention of Venous Thromboembolism and Cardiovascular Disease in Patients With Multiple Myeloma
October 04, 2017
Venous thromboembolism (VTE) and cardiovascular (CV) disease can occur in patients with multiple myeloma. Although VTE and CV disease are separate medical conditions, they can be serious and even life-threatening.
Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma
October 04, 2017
A majority of patients with multiple myeloma experience damage to the kidneys and peripheral nerves either at diagnosis or throughout the disease. Symptoms of diarrhea, nausea, vomiting, or constipation can also occur. Prevention and management of disease- and treatment-related side effects are essential to treatment adherence.
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma
October 04, 2017
The psychological needs of patients and caregivers may be inadvertently overlooked, contributing to the patient’s distress and possibly compromising outcomes. Untreated, these psychological needs may impair the patient’s ability to make decisions and adhere to treatment.
NLB Supplement CJON 2017
Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma
October 04, 2017
​Patients with multiple myeloma (MM) often deal with short- and long-term side effects of the treatment and disease sequelae. Reasons for inadequately managed symptoms are multifactorial (e.g., the patient may fear treatment interruption, the clinician does not assess or address the symptoms) and can affect patients’ ability to remain on the recommended treatment. This article provides background surrounding this supplement’s development and describes the importance of symptom assessment and management.
Steroid-Associated Side Effects
March 28, 2017

...

The Current Therapeutic Landscape and the Patient Experience
March 02, 2017

On December 2, 2016, 7 members of the International Myeloma Foundation (IMF) Nurse Leadership Board convened in San Diego, California, in...

IMF Nurse Newsletter, August 2016
August 01, 2016